EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars

Juntong Guo, Qinghan Tang, Zhengping Ge, Qing Xia, Hanmei Liu, Huaikai Shi, Jinlong Huang, Jun Chen, Mark S Cooper, Xin Yan, Chenxi Yang, Yiwei Wang iD

Burns & Trauma · 06.01.2026 · 14

DOI: 10.1093/burnst/tkag025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Burns & Trauma, online erschienen am 18.03.2026. Verfasst von Juntong Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Nanjing University of Chinese Medicine, Leading Program of Traditional Chinese Medicine First-class Discipline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic scars (HS) represent a significant clinical challenge due to their complex pathophysiology and resistance to conventional therapies, often resulting in persistent symptoms such as itching, pain, and impaired joint mobility that compromise patients’ quality of life. Current treatment modalities, including compression therapy, pharmacological agents, radiation, silicone gel, and laser therapies, have faced limitations primarily due to inadequate drug penetration into the dense fibrotic scar tissue. In this context, microneedle-mediated controlled delivery systems have emerged as a promising pharmaceutical platform to enhance localized and sustained delivery of therapeutic agents, including small-molecule drugs, biologic proteins, small interfering RNA, and living cells, directly into HS. This article critically reviews the biological and formulation-related challenges associated with transdermal delivery in scar tissue and highlights recent innovations in microneedle design, material selection, and drug-loading techniques tailored for controlled release applications. Furthermore, it discusses the integration of proteins and cell-based therapies within microneedle platforms and their potential to modulate scar remodeling and inflammation. By addressing current limitations and exploring cutting-edge technologies, this review article aims to guide the development of effective microneedle-mediated strategies for pharmaceutical intervention in hypertrophic scar management.

Schlagwörter

Stichwörter der Autor:innen

Drug delivery systemHypertrophic scarMicroneedleWound healing

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China.
  • Jiangsu Provincial Engineering Research Center of TCM External Medication Development and Application, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, PR China.
  • Department of Pharmacy, Nanjing Hospital of Chinese Medicine, 157 Daming Road, Nanjing 210022, Jiangsu, China.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing 210000, PR China.
  • Asbestos and Dust Diseases Research Institute, Concord Hospital, Gate 3 Hospital Road, Sydney, NSW 2138, Australia.
  • Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, 138 Xianlin Road, Nanjing University of Chinese Medicine, Nanjing 210023, PR China.

ORCID-Profile: Yiwei Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Nanjing University of Chinese Medicine
  • Leading Program of Traditional Chinese Medicine First-class Discipline
  • Nanjing Key Medical Laboratory for Research on Chinese Medicine Preparations and Clinical Pharmacy Construction Project

Zitieren

APA

Guo, J., Tang, Q., Ge, Z., Xia, Q., Liu, H., Shi, H., Huang, J., Chen, J., Cooper, M. S., Yan, X., Yang, C., & Wang, Y. (2026). Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars. Burns & Trauma, 14. https://doi.org/10.1093/burnst/tkag025

Vancouver

Guo J, Tang Q, Ge Z, Xia Q, Liu H, Shi H, et al. Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars. Burns & Trauma. 2026;14. doi:10.1093/burnst/tkag025

BibTeX
@article{Guo2026,
  author = {Guo, Juntong and Tang, Qinghan and Ge, Zhengping and Xia, Qing and Liu, Hanmei and Shi, Huaikai and Huang, Jinlong and Chen, Jun and Cooper, Mark S and Yan, Xin and Yang, Chenxi and Wang, Yiwei},
  title = {Advances in microneedle design for the delivery of drugs, proteins, and cells in the treatment of hypertrophic scars},
  journal = {Burns & Trauma},
  year = {2026},
  volume = {14},
  doi = {10.1093/burnst/tkag025}
}
Kostenlos starten →